Q BioMed Inc. Provides Update to Shareholders
NEW YORK, June 23, 2023 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides
PR NewswireJun 23, 2023 08:00 ET
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent From United States Patent Office and Notice of Allowance for Europe
Company's Liver Cancer Drug Candidate IP Portfolio strengthened Company provides operational update on strategic opportunities NEW YORK, April 14, 2023 /PRNewswire/ -- Q BioMed Inc. (OTCQB: QBIO) a
PR NewswireApr 14, 2023 08:06 ET
Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Up 24.6% in February
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 37,500 shares,
kopsourceMar 4, 2023 11:42 ET
Q BioMed Chemotherapy Uttroside B for Liver Cancer to Get US Patent
Seeking AlphaFeb 10, 2023 08:39 ET
Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent From United States Patent Office
Uttroside B Has Shown Promising Results in Initial Pre-Clinical Testing NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Q BioMed Inc. (OTCQB:QBIO) a biotech acceleration and commercial stage company focused on licensing and
PR NewswireFeb 10, 2023 08:05 ET
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Expands By 21.2%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant growth in short interest in the month of December. As of December 30th, there was short interest totalling 189,900 shares,
Defense WorldJan 22, 2023 03:51 ET
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Increases By 2,468.9%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 156,700 shares, a gr
kopsourceDec 28, 2022 13:11 ET
Q BioMed Inc. (OTCMKTS:QBIO) Short Interest Update
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large drop in short interest in the month of September. As of September 30th, there was short interest totalling 23,000 shares, a dro
kopsourceOct 13, 2022 20:22 ET
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Grows By 50.0%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 45,900 shares, an increase of 50.
kopsourceSep 16, 2022 22:21 ET
Traders News Source Senior Editor Mark Roberts Interviews Denis D Corin, CEO and Chairman Q BioMed Inc.
NEW YORK, NY / ACCESSWIRE / August 25, 2022 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap publicly traded companies recently issue
AccesswireAug 25, 2022 08:05 ET
Short Interest in Q BioMed Inc. (OTCMKTS:QBIO) Drops By 99.5%
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 100 shares, a drop of 99.5% fr
kopsourceJul 29, 2022 16:11 ET
Press Release: Q BioMed Inc. Provides Update to Shareholders
Q BioMed Inc. Provides Update to Shareholders PR Newswire NEW YORK, July 29, 2022 Company Reports Revenue Improvement and Positive Data on Pipeline Assets NEW YORK, July 29, 2022 /PRNewswire/ -- Q
Dow JonesJul 29, 2022 09:44 ET
Q BioMed Inc. (OTCMKTS:QBIO) Sees Significant Drop in Short Interest
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totalling 100 shares, a drop o
Financial News LiveJul 28, 2022 11:11 ET
Q BioMed Outlines Strategy and Value Proposition in Multi-Billion Dollar Markets
Management's assessment and value of Q BioMed outlined NEW YORK, May 6, 2022 /PRNewswire/ -- Q BioMed, Inc. (OTCQB:QBIO) a commercial-stage biotechnology development company outlines its strategy and value proposition for its stakeholders and sharehol
PR NewswireMay 6, 2022 08:32 ET
Q BioMed Inc. (OTCMKTS:QBIO) Sees Significant Growth in Short Interest
Q BioMed Inc. (OTCMKTS:QBIO – Get Rating) was the target of a significant increase in short interest in April. As of April 15th, there was short interest totalling 42,600 shares, an increase of 17.0%
ETF Daily NewsMay 5, 2022 12:02 ET
Q BioMed expands strontium89 to Chinese market with $500k order
Q BioMed (OTCQB:QBIO) said it received $500K order for its Strontium Chloride USP Injections under a supply contract between its Canadian distribution partner isoSolutions Marketing and Management, an
Seeking AlphaMar 7, 2022 09:40 ET
Q BioMed sees Q4 revenue to double on Strontium89 strength
Q BioMed (OTCQB:QBIO) said that it has seen an uptick in Strontium89 sales and expects revenue in Q4 to likely double than in previous quarters.The company's CEO Denis Corin called the start to the fo
Seeking AlphaSep 28, 2021 08:56 ET
No Data
No Data